Bryan J. McMichael - 07 Jan 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature: /s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Issuer symbol: CHRS
Transactions as of: 07 Jan 2023
Net transactions value: -$16,276
Form type: 4
Filing time: 10 Jan 2023, 15:40:35 UTC
Previous filing: 06 Jan 2023
Next filing: 24 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHRS	Common Stock	Tax liability	$16,276	-1,699	-11%	$9.58	13,886	07 Jan 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
F2	Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan.

Remarks:

Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer